Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)

• Product Name Alternative:

  MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors

• Synonyms:

  Preferentially Expressed Antigen In Melanoma

• UniProt:

  P78395

• Expression System:

  Prokaryotic expression

• Host:

  E. coli

• Tag:

  N-terminal His Tag

• Source:

  Prokaryotic expression

• Applications:

  Positive Control; Immunogen; SDS-PAGE; WB.

• Field of Research:

  Tumor immunity

• Endotoxin:

  < 1.0 EU per 1 µg (determined by the LAL method)

• Purity:

  > 90%

• Form:

  Freeze-Dried Powder

• Buffer:

  PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

• Calculated Molecular Weight:

  11.1 KDa

• Observed Molecular Weight:

  14&16kDa

• Fragment:

  Asn416~Leu502

• Isoelectric Point:

  6.2

• Subcellular Location:

  Membrane, Nucleus

• Organism Species:

  Homo sapiens (Human)

• CAS Number:

  9000-83-3